Mitokinin
Jessica Li has a diverse work experience. Jessica started their career in 2013 as a Laboratory Assistant at Monta Vista High School and a Teacher at Happy Childhood Learning Center. In 2016, they worked as a Research Assistant at UC Davis Department of Pharmacology in the Bers-Bossuyt Lab, Biochemistry Division, and a Hospital Intern in the Cardiology Department at UC Davis Medical Center. Jessica also presented a research project at the 2017 UC Davis Undergraduate Research Conference. From 2018 to 2021, they worked as a Life Science Research Professional 1 at Stanford University School of Medicine, and is currently employed as a Research Associate at Mitokinin Inc.
Jessica Li graduated from the University of California, Davis in 2018 with a Bachelor of Science in Cell/Cellular and Molecular Biology.
Mitokinin
Mitokinin is operates in the healthcare industry focusing on biotechnology business. Mitokinin has advanced small molecule therapeutics that specifically increase the activity of active-form PINK1. Importantly, Mitokinin’s compounds do not interfere with the endogenous regulation of PINK1. PINK1 is a master regulator of mitochondrial quality control. Mutations in PINK1 give rise to familial forms of Parkinson’s disease. Increased PINK1 activity rescues pathologies associated with neurodegenerative disease. Mitokinin has an accomplished team of neuroscientists, chemists, pharmacologists, and administrative professionals all focused on our mission: delivering disease-modifying therapies for neurodegenerative disease.